Recent population data have demonstrated a 50% reduction in legal blindness caused by age-related macular degeneration in certain nations following the advent of drugs that decrease vascular endothelial growth factor (VEGF), known as VEGF antagonists. The gene discussed is VEGFA; the disease is age-related macular degeneration.